Effect of Ginseng on Glycemic Control: A Systematic Review and Meta-analysis of Controlled Trials to Provide Evidence-based Clinical Recommendations
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Unity Health Toronto
- Enrollment
- 770
- Locations
- 1
- Primary Endpoint
- Glycated hemoglobin (HbA1c)
Study Overview
Brief Summary
Ginseng (American ginseng, Asian ginseng, Korean ginseng etc) is expected to show positive hypoglycemic effects, including improvements in glycated blood proteins[HbA1c], fasting glucose, fasting insulin, and the homeostasis model assessment of insulin resistance [HOMA-IR]).
Detailed Description
Ginseng has demonstrated to have significant hypoglycemic effect. Its major pharmacological component is considered to be ginsenosides. Several trials have been undertaken in diabetes some of which have demonstrated advantages in glycemic control in both diabetic as well as non diabetic individuals although clinical consistency of results is lacking.The lack of high quality data in this area to support diabetes recommendations represents an urgent call for stronger evidence. A systematic review and meta-analysis of controlled trials remains the "Gold Standard" of evidence for recommendations and clinical guidelines development. Therefore, investigators will conduct a systematic review and meta-analyses of controlled trials to assess the effect of ginseng on glycemic control.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Dietary trials in humans
- •Randomized treatment allocation
- •Suitable control
- •Viable endpoint data
Exclusion Criteria
- •Non-human studies
- •Non-randomized treatment allocation
- •<1 month
- •Lack of a suitable control
- •No viable endpoint data
Outcomes
Primary Outcomes
Glycated hemoglobin (HbA1c)
Time Frame: 1month
Secondary Outcomes
- Fasting blood glucose(1month)
- Fasting plasma insulin(1 month)
- Homeostasis model assessment of insulin resistance (HOMA-IR)(1 month)